NCT00752414View on ClinicalTrials.gov

A Phase 1b Study to Evaluate the Safety and PK of MP-376 in Chronic Obstructive Pulmonary Disease (COPD) Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

MP-376 (Levofloxacin solution for Inhalation)

Daily for 5 days

DRUG

Placebo

same frequency as MP-376

Trial Locations (5)

14215

Buffalo

36608

Mobile

43210

Columbus

68154

Omaha

85006

Phoenix

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY